America September 6, 2024
Bicara Therapeutics $200M IPO for Cancer Drug Development
Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…
America September 6, 2024
Bicara Therapeutics Inc., a Boston-based clinical-stage biopharmaceutical company, announced on Friday its plans to raise approximately $200 million through an…
By Rihem Akkouche
America August 30, 2024
Mountain Crest Acquisition Corp. V, a blank check company advised by Loeb & Loeb LLP, has announced a merger agreement…
By Rihem Akkouche
America June 27, 2024
Sichenzia Ross Ference Carmel LLP is advising Infintium Fuel Cell Systems Inc. on a blank-check company consolidation deal that values…
By Rihem Akkouche
America June 6, 2024
An Italian natural gas producer has revealed plans to merge with a Nasdaq-listed blank check company to boost its transition…
By Rihem Akkouche

